Pertussis Outbreak Described in Preschool in Tallahassee

Share this content:
Pertussis Outbreak Described in Preschool in Tallahassee
Pertussis Outbreak Described in Preschool in Tallahassee

MONDAY, Jan. 18, 2016 (HealthDay News) -- A report published online Jan. 13 in the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases highlights a 2013 pertussis outbreak among mainly vaccinated preschool-aged children.

James Matthias, M.P.H., from the Florida Department of Health in Tallahassee, and colleagues describe an outbreak of pertussis in Tallahassee. The outbreak occurred in a preschool with few vaccine exemptions; five of the 117 children had not received the complete series of vaccinations.

The researchers were notified of a laboratory-confirmed pertussis case in a 1-year-old vaccine-exempt preschool attendee in September 2013. Twenty-six students aged 1 to 5 years, two staff members from the same preschool, and 11 family members met the national case definition for pertussis during a five-month period. During this outbreak, four individuals were hospitalized for clinical management of symptoms. Two of the five students who had not received the complete set of vaccinations were diagnosed with pertussis. For all students who received the complete series of vaccinations for pertussis, the attack rates in one classroom approached 50 percent.

"This outbreak raises concerns about vaccine effectiveness in this preschool age group and reinforces the idea that recent pertussis vaccination should not dissuade physicians from diagnosing, testing, or treating persons with compatible illness for pertussis," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »